Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.

NCT00208000 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT00208000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00208000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.
Lead sponsor
China Medical University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2004
Completion date
April 30, 2006
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

"hyperuricemia,anserine"